Skip to content

A randomized controlled trial of foam sclerotherapy combined with laser VS foam sclerotherapy in the treatment of varicose veins of lower extremities

A randomized controlled trial of foam sclerotherapy combined with laser VS foam sclerotherapy in the treatment of varicose veins of lower extremities

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IIR-16008713
Enrollment
Unknown
Registered
2016-06-24
Start date
2017-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Varicose veins of lower extremity

Interventions

1:f foam sclerotherapy combined with laser
2:foam sclerotherapy

Sponsors

First Affiliated Hospital, Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. diagnosis of lower extremity varicose veins (B ultrasound); 2. aged 18-80 years old; 3. CEAP grade 1-4.

Exclusion criteria

Exclusion criteria: 1. Patient not suitable for surgical treatment of varicose veins of the lower extremity 2. patients with diabetes, cardiovascular and cerebrovascular disease, lower extremity arterial disease, lower extremity skin infection of patients; 3. patients with a history of deep venous thrombosis sequelae (PTS), KT syndrome or arteriovenous fistula in patients with non primary varicose veins; 4. patients with deep venous valve insufficiency; 5. patients who had undergone surgery for varicose veins of lower limb; 6. patients with capillary dilation; 7. patients with a history of lower extremity venous inflammation; 8. pregnant women; 9. great saphenous vein was distorted, not suitable for the treatment of patients with endovenous laser therapy.

Design outcomes

Primary

MeasureTime frame
recrudescence;Trunk closure;pulmonary embolism;

Secondary

MeasureTime frame
Ecchymosis, subcutaneous congestion;Subcutaneous induration;Pain;swelling;Numbness, sensory abnormalities;ulcer;not complete;allergy;Pigmentation;Branch closure;Length of stay;

Countries

China

Contacts

Public ContactHu Ming

Department of Vascular Surgery ,First Affiliated Hospital, Guangxi Medical University

462630421@qq.com+86 13471017307

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026